Nutritional advances in patients with respiratory diseases

European Respiratory Review

Volumn 24, Issue 135, 2015, Pages 17-22

  Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPHAGY; BODY COMPOSITION; CARDIOMETABOLIC RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LYSOSOME; MUSCLE ATROPHY; MUSCLE MASS; NUTRITIONAL STATUS; OBESITY; PHENOTYPE; PRIMARY PREVENTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SECONDARY PREVENTION; THORAX RADIOGRAPHY; METABOLISM; RESPIRATORY TRACT DISEASES;

HUMANS; NUTRITIONAL STATUS; OBESITY; RESPIRATORY TRACT DISEASES;

EID: 84923933892     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00010914     Document Type: Article

References (49)

1. Chung JH, Hwang HJ, Han CH, et al. Association between sarcopenia and metabolic syndrome in chronic obstructive pulmonary disease: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD 2014 [in press DOI: 10.3109/15412555.2014.908835].
2. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629–635.
3. Granell R, Henderson AJ, Evans DM, et al. Effects of BMI, fat mass, and lean mass on asthma in childhood: a Mendelian randomization study. PLoS Med 2014; 11: e1001669.
4. Yiallouros PK, Lamnisos D, Kolokotroni O, et al. Associations of body fat percent and body mass index with childhood asthma by age and gender. Obesity 2013; 21: E474–E482.
5. Chen YC, Tu YK, Huang KC, et al. Pathway from central obesity to childhood asthma. Physical fitness and sedentary time are leading factors. Am J Respir Crit Care Med 2014; 189: 1194–1203.
6. Han YY, Forno E, Celedon JC. Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med 2014; 190: 32–39.
7. Bradley GM, Blackman SM, Watson CP, et al. Genetic modifiers of nutritional status in cystic fibrosis. Am J Clin Nutr 2012; 96: 1299–1308.
8. Stephenson AL, Mannik LA, Walsh S, et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr 2013; 97: 872–877.
9. Panagopoulou P, Fotoulaki M, Nikolaou A, et al. Prevalence of malnutrition and obesity among cystic fibrosis patients. Pediatr Int 2014; 56: 89–94.
10. Hanna RM, Weiner DJ. Overweight and obesity in patients with cystic fibrosis: a center-based analysis. Pediatr Pulmonol 2015; 50: 35–41.
11. Behrens G, Matthews CE, Moore SC, et al. Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease. CMAJ 2014; 186: E457–E469.
12. Varraso R, Fung TT, Hu FB, et al. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax 2007; 62: 786–791.
13. Varraso R, Jiang R, Barr RG, et al. Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men. Am J Epidemiol 2007; 166: 1438–1445.
14. Fonseca Wald EL, van den Borst B, Gosker HR, et al. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review. Respirology 2013; 19: 176–184.
15. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728–735.
16. Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44: 1504–1520.
17. Van Remoortel H, Hornikx M, Langer D, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: 30–38.
18. van den Borst B, Koster A, Yu B, et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 2011; 66: 961–969.
19. van den Borst B, Gosker HR, Koster A, et al. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr 2012; 96: 516–526.
20. van den Borst B, Gosker HR, Schols AM. Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 8–13.
21. van den Borst B, Slot IG, Hellwig VA, et al. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol (1985) 2013; 114: 1319–1328.
22. Gagnon P, Lemire BB, Dube A, et al. Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respir Res 2014; 15: 4.
23. Remels AH, Gosker HR, Langen RC, et al. Classical NF-kappaB activation impairs skeletal muscle oxidative phenotype by reducing IKK-alpha expression. Biochim Biophys Acta 2014; 1842: 175–185.
24. Natanek SA, Gosker HR, Slot IG, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? Muscle Nerve 2013; 48: 488–497.
25. Gouzi F, Abdellaoui A, Molinari N, et al. Fiber atrophy, oxidative stress, and oxidative fiber reduction are the attributes of different phenotypes in chronic obstructive pulmonary disease patients. J Appl Physiol (1985) 2013; 115: 1796–1805.
26. Maddocks M, Shrikrishna D, Vitoriano S, et al. Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD. Eur Respir J 2014; 44: 1188–1198.
27. Micklesfield LK, Goedecke JH, Punyanitya M, et al. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity (Silver Spring) 2012; 20: 1109–1114.
28. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing 2010; 39: 412–423.
29. Prado CM, Siervo M, Mire E, et al. A population-based approach to define body-composition phenotypes. Am J Clin Nutr 2014; 99: 1369–1377.
30. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539–1547.
31. Romme EA, Murchison JT, Edwards LD, et al. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res 2013; 28: 1369–1377.
32. Park MJ, Cho JM, Jeon KN, et al. Mass and fat infiltration of intercostal muscles measured by CT histogram analysis and their correlations with COPD severity. Acad Radiol 2014; 21: 711–717.
33. McDonald ML, Diaz AA, Ross JC, et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc 2014; 11: 326–334.
34. Schols AM, Mostert R, Soeters PB, et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695–699.
35. Clark RV, Walker AC, O’Connor-Semmes RL, et al. Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans. J Appl Physiol (1985) 2014; 116: 1605–1613.
36. Prado CM, Sawyer MB, Ghosh S, et al. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr 2013; 98: 1012–1019.
37. Aapro M, Arends J, Bozzetti F, et al. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol 2014; 25: 1492–1499.
38. Rutten EP, Lenaerts K, Buurman WA, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 2014; 145: 245–252.
39. Jonker R, Deutz NE, Erbland ML, et al. Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion. Clin Nutr 2014; 33: 211–220.
40. Engelen MP, De Castro CL, Rutten EP, et al. Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids. Clin Nutr 2012; 31: 616–624.
41. Ferreira IM, Brooks D, White J, et al. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12: CD000998.
42. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr 2012; 95: 1385–1395.
43. Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology 2013; 18: 616–629.
44. Constantin D, Menon MK, Houchen-Wolloff L, et al. Skeletal muscle molecular responses to resistance training and dietary supplementation in COPD. Thorax 2013; 68: 625–633.
45. Langen RC, Gosker HR, Remels AH, et al. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013; 45: 2245–2256.
46. Guo Y, Gosker HR, Schols AM, et al. Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 1313–1320.
47. Op den Kamp CM, Langen RC, Snepvangers FJ, et al. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr 2013; 98: 738–748.
48. Theriault ME, Pare ME, Lemire BB, et al. Regenerative defect in vastus lateralis muscle of patients with chronic obstructive pulmonary disease. Respir Res 2014; 15: 35.
49. He WA, Berardi E, Cardillo VM, et al. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 2013; 123: 4821–4235.